(Press-News.org) It remains an unresolved question whether adult patients with Hodgkin's lymphoma, a certain type of lymph node cancer, benefit from allogeneic stem cell transplantation (SCT) with an unrelated donor. This is due to the fact that studies are lacking that compare this therapy with autologous transplantation or conventional chemotherapy without SCT. In addition, the few studies comparing SCT with an unrelated donor versus SCT with a related donor provide neither proof nor indications of an advantage. However, it cannot be inferred from the studies that both procedures are equivalent. Nevertheless, in IQWiG's opinion, under specific conditions it is justified to offer certain patients allogeneic SCT, including transplantation with an unrelated donor. This is the result of a final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 27 September.
Relatively rare disease
Hodgkin's lymphoma is a relatively rare malignant disease of the haemopoietic system. About 2000 people are newly affected in Germany every year. For these patients, standard treatment comprises a combination of chemo- and radiation therapy; about 80% of patients are cured in this way. However, in the remaining patients, tumour cells do not respond to treatment or patients experience a relapse after initially successful therapy. In certain cases, subsequent treatment with SCT is therefore recommended.
In this procedure, the patient's affected bone marrow is first destroyed with high-dose chemotherapy (conditioning). Stem cells of a donor are then transplanted and settle in the bone marrow. The procedure is called autologous SCT if the transplanted stem cells originate from the patients themselves. They are taken from the patient's own body before high-dose chemotherapy and then reinfused. If the transplant originates from a different donor, the procedure is called allogeneic SCT. In this context a distinction is made between related and unrelated donors.
In principle, SCT is an intervention fraught with risk, as there is quite a substantial risk of death resulting from conditioning, or of suffering other serious treatment-related complications. For example, donor cells may attack organs of the recipient (graft-versus-host disease).
Still an experimental procedure
If the Hodgkin's lymphoma recurs, professional societies first recommend autologous SCT. The chances of curing the disease with this treatment are about 50%. In patients in whom the tumour recurs even after one or several autologous transplantations, allogeneic SCT can be considered as a treatment option under certain conditions. However, this procedure is still regarded as experimental. Between 1998 and 2008, a total of 167 patients with Hodgkin's lymphoma underwent allogeneic SCT in Germany; about half of them received a transplant from an unrelated donor.
The Federal Joint Committee (G-BA) commissioned IQWiG to assess allogeneic SCT with an unrelated donor. For this purpose, adult patients who underwent this procedure were to be compared with those who underwent autologous transplantation or chemotherapy without SCT. In addition, among other things, the benefits and harms were to be compared between allogeneic SCT with an unrelated donor versus allogeneic SCT with a related donor.
Studies only available for one research question
IQWiG could only find studies on the last research question. This was disappointing as the Institute had conducted a very broad literature search and had also included study types that are in principle of only limited informative value, such as registry data. Ultimately 8 studies (including 2 registry analyses) were available for the comparison between unrelated and related donors in allogeneic SCT.
It could not be clearly inferred from these studies which donor type offered the better prospects of success in patients with Hodgkin's lymphoma. Overall the studies were rather small and of poor quality and did not contain information on many aspects. This uncertainty also applies to adverse effects and complications. It is an essential issue that the studies did not allow conclusions as to whether the two procedures are equivalent.
Inform patients about uncertain evidence base
IQWiG identified a few studies on allogeneic transplantation that could not however be included in the assessment, as the results did not distinguish between related and unrelated donors. In these studies, a reduced-intensity conditioning regimen was applied, which is nowadays standard treatment in patients with Hodgkin's lymphoma who undergo allogeneic SCT. This treatment variant is less aggressive (toxic) and therefore better tolerated. These studies indicate that patients who received allogeneic SCT with a reduced-intensity conditioning regimen survived longer than patients who had been treated with chemo- and/or radiotherapy alone.
All patients in these studies had already undergone one or more unsuccessful therapy attempts (including autologous transplantation). Despite the gaps in knowledge, in IQWiG's opinion it is therefore justified to offer allogeneic transplantation with a reduced-intensity conditioning regimen to these patients, including transplantation with an unrelated donor, as other therapy alternatives are not available to them. In order to close knowledge gaps, IQWiG recommends a separate analysis of data on transplants from related and unrelated donors in all future studies and publications. This also and specifically refers to studies that include a comparison with treatment without allogeneic SCT.
In IQWiG's opinion, it is indispensable that patients are informed in full detail about the currently still uncertain evidence base before any decision for or against allogeneic transplantation is made.
INFORMATION:
Procedure of report production
IQWiG published the preliminary results in the form of the preliminary report at the beginning of May 2010 and interested parties were invited to submit comments. When the comments stage ended, the preliminary report was revised and sent as a final report to the contracting agency, the Federal Joint Committee, at the beginning of August 2010. As only one written comment was received, which moreover raised no questions, IQWiG dispensed with an oral debate. The written comments are published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.
END
Boston, Mass. -- A national epidemiologic study finds a strong, consistent correlation between adult diabetes and particulate air pollution that persists after adjustment for other risk factors like obesity and ethnicity, report researchers from Children's Hospital Boston. The relationship was seen even at exposure levels below the current EPA safety limit.
The report, published in the October issue of Diabetes Care, is among the first large-scale population-based studies to link diabetes prevalence with air pollution. It is consistent with prior laboratory studies finding ...
Blueberries may help fight atherosclerosis, also known as hardening of the arteries, according to results of a preliminary U.S. Department of Agriculture (USDA)-funded study with laboratory mice. The research provides the first direct evidence that blueberries can help prevent harmful plaques or lesions, symptomatic of atherosclerosis, from increasing in size in arteries.
Principal investigator Xianli Wu, based in Little Rock, Ark., with the USDA Agricultural Research Service (ARS) Arkansas Children's Nutrition Center and with the University of Arkansas for Medical Sciences, ...
Philadelphia, PA, September 29, 2010 – Premature infants are often examined for retinopathy of prematurity (ROP). This exam can be quite stressful for the neonate, causing changes in heart rate, blood pressure and oxygen saturation, and increased crying. In a recent study published in the Journal of AAPOS, the Official Publication of the American Association of Pediatric Ophthalmology and Strabismus, researchers found that feeding infants one hour before the examination unexpectedly reduced stress but did not increase vomiting or gastric aspirates.
Investigators from ...
DURHAM, N.C. -- Flicking through a wallpaper app with backgrounds of Mickey Mouse and a tropical waterfall, Peter Gilbert gets a plain, black and white text notification on his smartphone.
A third of the way down the screen it says, "Taint: Phone Number, IMEI, ICCID (sim card identifier)." The message alerts Gilbert that the wallpaper app has sent his phone's number and other identifying information to imnet.us. Checking online, it appears the address is a website in Shenzhen, China.
The notification came from TaintDroid, a prototype extension to the Android mobile-phone ...
Troy, N.Y. – The purification of drug components is a large hurdle facing modern drug development. This is particularly true of drugs that utilize proteins, which are notoriously difficult to separate from other potentially deadly impurities. Scientists within the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute are using nuclear magnetic resonance (NMR) to understand and improve an important protein purification process.
"We hope to use our insights to help those in the industry develop improved processes to provide ...
Publicly available cell-phone applications from application markets are releasing consumers' private information to online advertisers, according to a joint study by Intel Labs, Penn State, and Duke University.
Researchers at the participating institutions have developed a realtime monitoring service called TaintDroid that precisely analyses how private information is obtained and released by
applications "downloaded" to consumer phones. TaintDroid is an extension to the Android mobile-phone platform that tracks the flow of sensitive data through third-party applications.
In ...
MANHATTAN, KAN. -- For two Kansas State University professors, receiving one of software engineering's most prestigious awards was more than 10 years in the making.
A seven-member research team that included K-State's John Hatcliff, professor of computer and information science, and Robby, associate professor of computing and information science, set out in 1998 to illustrate how different technologies could test for problems that arise when computer programs multitask. The team published "Bandera: Extracting Finite-State Models from Java Source code" in 2000.
The publication ...
A new approach to anchor teeth back in the jaw using stem cells has been developed and successfully tested in the laboratory for the first time by researchers at the University of Illinois at Chicago.
The new strategy represents a potential major advance in the battle against gum disease, a serious infection that eventually leads to tooth loss. About 80 percent of U.S. adults suffer from gum disease, according to the National Institute of Dental and Craniofacial Research.
Researchers in UIC's Brodie Laboratory for Craniofacial Genetics used stem cells obtained from ...
PHILADELPHIA – After experiencing a potentially traumatic event – a car accident, a physical or sexual assault, a sports injury, witnessing violence – as many as 1 in 5 children will develop Posttraumatic Stress Disorder (PTSD).
A new approach that helps improve communication between child and caregiver, such as recognizing and managing traumatic stress symptoms and teaching coping skills, was able to prevent chronic and sub-clinical PTSD in 73 percent of children. The intervention, called the Child and Family Traumatic Stress Intervention (CFTSI) also reduced PTSD symptoms ...
INDIANAPOLIS -- Researchers at the Indiana University Melvin and Bren Simon Cancer Center have published the first report using imaging to show that changes in brain tissue can occur in breast cancer patients undergoing chemotherapy.
The cognitive effects of chemotherapy, often referred to as "chemobrain," have been known for years. However, the IU research is the first to use brain imaging to study women with breast cancer before and after treatment, showing that chemotherapy can affect gray matter. The researchers reported their findings in the October 2010 edition ...
